HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Josep Ordi-Ros Selected Research

Livedo Reticularis

11/2019Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
5/2009Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Josep Ordi-Ros Research Topics

Disease

12Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2017 - 07/2002
6Lupus Nephritis
02/2020 - 12/2010
3Fibrosis (Cirrhosis)
02/2020 - 09/2015
3Thrombosis (Thrombus)
01/2020 - 05/2009
2Inflammation (Inflammations)
01/2020 - 01/2019
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2019 - 11/2009
2Livedo Reticularis
11/2019 - 05/2009
2Proteinuria
09/2019 - 12/2010
2Cutaneous Lupus Erythematosus
01/2019 - 12/2012
2Neoplasms (Cancer)
08/2010 - 09/2009
2Autoimmune Diseases (Autoimmune Disease)
08/2010 - 06/2007
1Discoid Lupus Erythematosus
01/2020
1Stroke (Strokes)
11/2019
1Hemorrhage
11/2019
1Disease Progression
11/2017
1Cystitis
11/2017
1Arthritis (Polyarthritis)
06/2015
1Chronic Renal Insufficiency
09/2014
1Congenital Abnormalities (Deformity)
04/2014
1Fatigue
08/2011
1Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
08/2011
1Common Variable Immunodeficiency
04/2011
1Oral Ulcer (Mouth Ulcer)
01/2011
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2009
1Chronic Disease (Chronic Diseases)
09/2009
1Kidney Diseases (Kidney Disease)
08/2009
1Lymphopenia (Lymphocytopenia)
07/2008
1Hereditary Hemorrhagic Telangiectasia
06/2007
1Connective Tissue Diseases (Connective Tissue Disease)
06/2007
1Pulmonary Arterial Hypertension
06/2007
1CREST Syndrome (Syndrome, CREST)
06/2007
1Pulmonary Hypertension
06/2007
1Nephritis
02/2004
1Glomerulonephritis
02/2004
1Atherosclerosis
07/2002
1Coronary Disease (Coronary Heart Disease)
07/2002

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
11/2019 - 05/2009
5DNA (Deoxyribonucleic Acid)IBA
08/2011 - 02/2004
4MicroRNAs (MicroRNA)IBA
02/2020 - 01/2019
4Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2010
4AntibodiesIBA
08/2010 - 07/2002
3AutoantibodiesIBA
01/2012 - 02/2004
2CreatinineIBA
09/2019 - 08/2009
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
09/2017 - 12/2010
2EnzymesIBA
09/2014 - 06/2007
1Thalidomide (Thalomid)FDA Link
01/2020
1AnticoagulantsIBA
11/2019
1RivaroxabanIBA
11/2019
1Vitamin KFDA Link
11/2019
1Neuropilin-1IBA
09/2019
1CytokinesIBA
01/2019
1AA amyloidosisIBA
11/2017
1Azathioprine (Imuran)FDA LinkGeneric
09/2017
1Etanercept (Enbrel)FDA Link
06/2015
1Lipocalin-2IBA
09/2014
1ImmunosorbentsIBA
09/2014
1Hypnotics and Sedatives (Sedatives)IBA
04/2014
1Lenalidomide (CC 5013)FDA Link
12/2012
1Biological ProductsIBA
08/2011
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
04/2011
1Tacrolimus (Prograf)FDA LinkGeneric
12/2010
1SuperantigensIBA
08/2010
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2009
1Anticardiolipin AntibodiesIBA
11/2009
1Retroelements (Retrotransposon)IBA
09/2009
1LipidsIBA
08/2009
1Phospholipids (Phosphatides)FDA LinkGeneric
05/2009
1CD40 Ligand (CD40L)IBA
05/2009
1Complement System Proteins (Complement)IBA
07/2008
1MethyltransferasesIBA
07/2008
1Deoxyribonucleases (DNase)FDA Link
05/2008
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
06/2007
1Activin Receptors (Activin Receptor)IBA
06/2007
1cyclo(Arg-Pro) (CI 4)IBA
02/2004
1anti-dsDNA autoantibodyIBA
02/2004
1oxidized low density lipoproteinIBA
07/2002
1Deoxyribonuclease I (Nickase)IBA
07/2002

Therapy/Procedure

3Therapeutics
02/2020 - 09/2014
1Time-to-Treatment
12/2010